Intercure (Intercure) YoY EBITDA Growth : -70.73% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Intercure YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Intercure's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was -70.73%.

Intercure's EBITDA per Share for the three months ended in Jun. 2023 was $0.04.

Intercure YoY EBITDA Growth Historical Data

The historical data trend for Intercure's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure YoY EBITDA Growth Chart

Intercure Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

71.61

-740.91

153.78

112.06

-133.89

Intercure Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															139.02	-102.13	-61.36	-70.73	-100.00

Intercure YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Intercure's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.143	-	0.422)	/	\| 0.422 \|
=	-133.89 %

Intercure's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2023 )
=	(EBITDA per Share (Q: Jun. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(0.036	-	0.123)	/	\| 0.123 \|
=	-70.73 %

Intercure YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Intercure's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Intercure (Intercure) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (NAS:INCR) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

INCR:Israel

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.